Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Retinal Detachment Clinical Trials
Retinal Detachment clinical trials are recruiting across 6 cities. Here are the cities with the most active studies:
Retinal Detachment Trial Phases
2 research organizations are sponsoring retinal detachment trials.
About Retinal Detachment
Retinal detachment is an emergency condition where the retina separates from the back of the eye, causing sudden vision loss. Risk factors include high myopia, previous eye surgery, and eye trauma. Treatment requires surgery such as pneumatic retinopexy, vitrectomy, or scleral buckle.
Clinical trials are advancing new treatments for retinal detachment. Currently, 2 studies are recruiting a combined 548 participants across the United States. Research is being conducted by 2 organizations including Helen Keller Eye Research Foundation, Massachusetts Eye and Ear Infirmary.
2026 Retinal Detachment Research Landscape
As of October 2026, the retinal detachment clinical trial landscape includes 2 actively recruiting studies across 6 cities in the United States. These studies are collectively seeking 548 participants, with an average enrollment target of 274 per study.
The research spans multiple phases of development: 1 study is in NA, 1 study is in PHASE1, 1 study is in PHASE2. Early-phase studies suggest new therapeutic approaches are being explored for retinal detachment.
Research is being led by 2 different organizations, including Helen Keller Eye Research Foundation, Massachusetts Eye and Ear Infirmary.
Geographically, retinal detachment trials are most concentrated in Birmingham, Alabama (1 trial); Royal Oak, Michigan (1 trial); Minneapolis, Minnesota (1 trial); Rochester, Minnesota (1 trial); Nashville, Tennessee (1 trial) and 1 other cities.
Featured Retinal Detachment Studies
Highlighted recruiting studies for retinal detachment, selected by enrollment size and research scope.
Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)
The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachment in SS in children and adults. Researchers will compare the OSC/SS procedure in SS to the natural progression of SS to see to what extent the OSC/SS procedure works to prevent retinal detachment. Participants will: * Have the OSC/SS pr...
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
This study has two main objectives. The first objective is to study the pharmacokinetics of topical netarsudil administration in the posterior segment of the eye, where netarsudil must exert its effect in order to prevent formation of tractional membranes. The second objective is to assess the safety profile of topical netarsudil in the pre- and post-operative periods. A secondary objective of th...
Frequently Asked Questions About Retinal Detachment Clinical Trials
Are there retinal detachment clinical trials near me?
Yes, there are 2 retinal detachment clinical trials currently recruiting across 6+ cities in the United States, including Birmingham, Alabama; Royal Oak, Michigan; Minneapolis, Minnesota. Browse the studies above to find one at a location convenient for you.
How do I join a retinal detachment clinical trial?
To join a retinal detachment clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are retinal detachment clinical trials free?
Yes, participation in retinal detachment clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of retinal detachment treatments are being studied?
Current retinal detachment clinical trials are testing a range of approaches across NA (1 study), PHASE1 (1 study), PHASE2 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in retinal detachment clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated October 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated October 14, 2026 · Data from ClinicalTrials.gov